Belzutifan for von Hippel–Lindau Disease–Associated Pancreatic Lesions
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study
Clin. Cancer Res 2024 Feb 23;[EPub Ahead of Print], T Else, E Jonasch, O Lliopoulos, KE Beckermann, V Narayan, BL Maughan, S Oudard, JK Maranchie, AB Iversen, CM Goldberg, W Fu, RF Perini, Y Liu, WM Linehan, R SrinivasanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.